The Antihistamine Drugs Market is expected to register a CAGR of 5.2% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the Antihistamine Drugs Market is segmented by type into sedating and non-sedating. Route of administration analyzed include oral, perental and Rectal. End-users include pharmaceutical companies, retail pharmacies, healthcare providers, and e-commerce platforms. The regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses. This report focuses on the growing demand for antihistamine drugs due to the rise in allergy-related disorders and increasing consumer preference for non-drowsy formulations.
Purpose of the ReportThe report Antihistamine Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antihistamine Drugs Market Segmentation
Type- Sedating
- Non-Sedating
- Oral Route
- Parenteral Route
- Rectal Route
- Allergy
- Urticaria
- Dermatitis
- Hospitals
- Clinics
- Pharmaceutical Companies
Strategic Insights
Antihistamine Drugs Market Growth Drivers- Increasing Allergic Reactions: Allergic conditions such as rhinitis, conjunctivitis, and asthma are on the rise globally. The WAO estimated that 10-30% of the population worldwide suffer from allergic rhinitis. This frequency and severity of allergies have been further increased due to various environmental factors, including pollution, change in climate, and rise in pollen levels. Because antihistamine drugs remain the symptomatic treatment for symptoms like sneezing, itching, and nasal congestion, this increasing prevalence of allergic reactions boosts the demand for antihistamine drugs.
- Increasing Pollution Levels: The rise in air pollution has been indeed considered the main culprit for increasing allergic diseases, especially in urban areas. One of the research studies that was published in the Journal of Allergy and Clinical Immunology showed how air pollution, especially fine particulate matter (PM2.5), acts as a trigger for allergic responses and increases the level of asthma symptoms. The increasing pollution levels raise higher demands for antihistamines to manage allergy-induced health issues.
- Aging Population: Due to this fact, the world's population is ageing. This leads to an increased number of allergic reactions in elderly people. Other health-related issues such as seasonal allergies, asthma are common in aged persons. The United Nations estimates that, by 2050, there will be around 2.1 billion people aged 60 years and above. As this number increases, so does demand for medications, including antihistamines, prescribed for symptomatic treatment of allergy.
- Trend Towards Non-Sedating Antihistamines: The trend of nonsedating antihistamines is catching up fast as patients show a growing preference for drugs devoid of sedation. Sedating antihistamines, though effective, possess a number of adverse effects like sedation and reduced alertness which interfere with daily activities. Cetirizine and loratadine are some of the drugs that are gaining popularity because they possess less sedation and therefore can be used for longer periods.
- Increased Usage of Over-the-Counter Antihistamines: The easy availability of antihistamines over the counter has been one of the major factors contributing toward the growth of the market. Most people opt for OTC antihistamines due to their immediate effectiveness in mild to moderate allergic symptoms. The sale of OTC antihistamines in the United States is growing continuously. The commonly available products such as Claritin, Zyrtec, and Benadryl are readily accessible at pharmacies and online.
- Combination Medications Continue to Grow in Popularity:
Combination-type antihistamine medications designed to provide multistate symptoms' relief develop. Products contain an antihistamine interaction with a decongestant or cortisone steroid hormone, among many others. Today, such single pills can improve nasal congestion as well as general swelling of various body parts apart from just easing general cold discomfort. Combination drugs remain very high on demand particularly among patients as it combines efficacy and convenience:.
- Invest in Digital Health and Telemedicine: Telemedicine and digital health platforms are finding their place in allergy management. Online consultations and prescriptions of antihistamine drugs are highly sought after, especially during allergy seasons. This opens up opportunities for pharmaceutical companies in cooperation with digital health platforms, fueled by the COVID-19 pandemic, thus offering convenience and reaching a broader customer base. Moreover, digital health solutions-for example, apps for allergy tracking-could also improve adherence to antihistamine treatment regimens.
- Potential in Pediatric and Geriatric Populations: Both pediatric and geriatric populations are vistas that drug manufacturers of antihistamines have not been effectively tapped. The pediatric population is quite commonly prone to allergic conditions, including rhinitis, while the geriatric population is usually more susceptible to allergy problems, including pollen and dust sensitivity. With new formulations of antihistamines targeted for both the pediatric and geriatric patient, specifically addressing their unique physiological needs and tolerances, such emerging markets' demands can be met.
- Innovations in Allergy Immunotherapy: Allergy immunotherapy is another emerging area for the desensitization of patients against the allergen; thus, supplementing antihistamines would be in tandem. As opposed to the mere symptomatic reliefs afforded by antihistamines, this course of action targets the cause of the reaction and can possibly offer long-term solutions. Investment by pharmaceutical firms in sublingual tablet allergen immunotherapy and injectable therapies stands the chance of ensuring increased demand, especially as regard effective, long-term treatments of allergies. Where this is likely to continue, antihistamine medication may be administered with immunotherapy to improve the outcomes of patients.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antihistamine Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antihistamine Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Antihistamine Drugs Market is expected to register a CAGR of 5.2% from 2025-2031.
The major driving factors supporting the Antihistamine Drugs Market growth are- Increasing Allergic Reactions, Increasing Pollution Levels, and Aging Population
Key Future Trends in the Antihistamine Drugs Market are- Trend Towards Non-Sedating Antihistamines, Increased Usage of Over-the-Counter Antihistamines, and Combination Medications Continue to Grow in Popularity
Key companies in Antihistamine Drugs Market are - Bayer AG , AlmirallSA , JohnsonandJohnson , AstraZenecaPlc , NovartisAG , PfizerInc , SanofiSA , BoehringerIngelheimGmbH , MerckandCoInc
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antihistamine Drugs Market - By Type
1.3.2 Antihistamine Drugs Market - By Route of Administration
1.3.3 Antihistamine Drugs Market - By Indication
1.3.4 Antihistamine Drugs Market - By End User
1.3.5 Antihistamine Drugs Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIHISTAMINE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIHISTAMINE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIHISTAMINE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIHISTAMINE DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIHISTAMINE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIHISTAMINE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SEDATING
7.3.1. Overview
7.3.2. Sedating Market Forecast and Analysis
7.4. NON-SEDATING
7.4.1. Overview
7.4.2. Non-Sedating Market Forecast and Analysis
8. ANTIHISTAMINE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL ROUTE
8.3.1. Overview
8.3.2. Oral Route Market Forecast and Analysis
8.4. PARENTERAL ROUTE
8.4.1. Overview
8.4.2. Parenteral Route Market Forecast and Analysis
8.5. RECTAL ROUTE
8.5.1. Overview
8.5.2. Rectal Route Market Forecast and Analysis
9. ANTIHISTAMINE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. ALLERGY
9.3.1. Overview
9.3.2. Allergy Market Forecast and Analysis
9.4. URTICARIA
9.4.1. Overview
9.4.2. Urticaria Market Forecast and Analysis
9.5. DERMATITIS
9.5.1. Overview
9.5.2. Dermatitis Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. others Market Forecast and Analysis
10. ANTIHISTAMINE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. PHARMACEUTICAL COMPANIES
10.5.1. Overview
10.5.2. Pharmaceutical Companies Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. others Market Forecast and Analysis
11. ANTIHISTAMINE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Antihistamine Drugs Market Overview
11.1.2 North America Antihistamine Drugs Market Forecasts and Analysis
11.1.3 North America Antihistamine Drugs Market Forecasts and Analysis - By Type
11.1.4 North America Antihistamine Drugs Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Antihistamine Drugs Market Forecasts and Analysis - By Indication
11.1.6 North America Antihistamine Drugs Market Forecasts and Analysis - By End User
11.1.7 North America Antihistamine Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Antihistamine Drugs Market
11.1.7.1.1 United States Antihistamine Drugs Market by Type
11.1.7.1.2 United States Antihistamine Drugs Market by Route of Administration
11.1.7.1.3 United States Antihistamine Drugs Market by Indication
11.1.7.1.4 United States Antihistamine Drugs Market by End User
11.1.7.2 Canada Antihistamine Drugs Market
11.1.7.2.1 Canada Antihistamine Drugs Market by Type
11.1.7.2.2 Canada Antihistamine Drugs Market by Route of Administration
11.1.7.2.3 Canada Antihistamine Drugs Market by Indication
11.1.7.2.4 Canada Antihistamine Drugs Market by End User
11.1.7.3 Mexico Antihistamine Drugs Market
11.1.7.3.1 Mexico Antihistamine Drugs Market by Type
11.1.7.3.2 Mexico Antihistamine Drugs Market by Route of Administration
11.1.7.3.3 Mexico Antihistamine Drugs Market by Indication
11.1.7.3.4 Mexico Antihistamine Drugs Market by End User
11.2. EUROPE
11.2.1 Europe Antihistamine Drugs Market Overview
11.2.2 Europe Antihistamine Drugs Market Forecasts and Analysis
11.2.3 Europe Antihistamine Drugs Market Forecasts and Analysis - By Type
11.2.4 Europe Antihistamine Drugs Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Antihistamine Drugs Market Forecasts and Analysis - By Indication
11.2.6 Europe Antihistamine Drugs Market Forecasts and Analysis - By End User
11.2.7 Europe Antihistamine Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Antihistamine Drugs Market
11.2.7.1.1 Germany Antihistamine Drugs Market by Type
11.2.7.1.2 Germany Antihistamine Drugs Market by Route of Administration
11.2.7.1.3 Germany Antihistamine Drugs Market by Indication
11.2.7.1.4 Germany Antihistamine Drugs Market by End User
11.2.7.2 France Antihistamine Drugs Market
11.2.7.2.1 France Antihistamine Drugs Market by Type
11.2.7.2.2 France Antihistamine Drugs Market by Route of Administration
11.2.7.2.3 France Antihistamine Drugs Market by Indication
11.2.7.2.4 France Antihistamine Drugs Market by End User
11.2.7.3 Italy Antihistamine Drugs Market
11.2.7.3.1 Italy Antihistamine Drugs Market by Type
11.2.7.3.2 Italy Antihistamine Drugs Market by Route of Administration
11.2.7.3.3 Italy Antihistamine Drugs Market by Indication
11.2.7.3.4 Italy Antihistamine Drugs Market by End User
11.2.7.4 Spain Antihistamine Drugs Market
11.2.7.4.1 Spain Antihistamine Drugs Market by Type
11.2.7.4.2 Spain Antihistamine Drugs Market by Route of Administration
11.2.7.4.3 Spain Antihistamine Drugs Market by Indication
11.2.7.4.4 Spain Antihistamine Drugs Market by End User
11.2.7.5 United Kingdom Antihistamine Drugs Market
11.2.7.5.1 United Kingdom Antihistamine Drugs Market by Type
11.2.7.5.2 United Kingdom Antihistamine Drugs Market by Route of Administration
11.2.7.5.3 United Kingdom Antihistamine Drugs Market by Indication
11.2.7.5.4 United Kingdom Antihistamine Drugs Market by End User
11.2.7.6 Rest of Europe Antihistamine Drugs Market
11.2.7.6.1 Rest of Europe Antihistamine Drugs Market by Type
11.2.7.6.2 Rest of Europe Antihistamine Drugs Market by Route of Administration
11.2.7.6.3 Rest of Europe Antihistamine Drugs Market by Indication
11.2.7.6.4 Rest of Europe Antihistamine Drugs Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Antihistamine Drugs Market Overview
11.3.2 Asia-Pacific Antihistamine Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Antihistamine Drugs Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Antihistamine Drugs Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Antihistamine Drugs Market Forecasts and Analysis - By Indication
11.3.6 Asia-Pacific Antihistamine Drugs Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Antihistamine Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Antihistamine Drugs Market
11.3.7.1.1 Australia Antihistamine Drugs Market by Type
11.3.7.1.2 Australia Antihistamine Drugs Market by Route of Administration
11.3.7.1.3 Australia Antihistamine Drugs Market by Indication
11.3.7.1.4 Australia Antihistamine Drugs Market by End User
11.3.7.2 China Antihistamine Drugs Market
11.3.7.2.1 China Antihistamine Drugs Market by Type
11.3.7.2.2 China Antihistamine Drugs Market by Route of Administration
11.3.7.2.3 China Antihistamine Drugs Market by Indication
11.3.7.2.4 China Antihistamine Drugs Market by End User
11.3.7.3 India Antihistamine Drugs Market
11.3.7.3.1 India Antihistamine Drugs Market by Type
11.3.7.3.2 India Antihistamine Drugs Market by Route of Administration
11.3.7.3.3 India Antihistamine Drugs Market by Indication
11.3.7.3.4 India Antihistamine Drugs Market by End User
11.3.7.4 Japan Antihistamine Drugs Market
11.3.7.4.1 Japan Antihistamine Drugs Market by Type
11.3.7.4.2 Japan Antihistamine Drugs Market by Route of Administration
11.3.7.4.3 Japan Antihistamine Drugs Market by Indication
11.3.7.4.4 Japan Antihistamine Drugs Market by End User
11.3.7.5 South Korea Antihistamine Drugs Market
11.3.7.5.1 South Korea Antihistamine Drugs Market by Type
11.3.7.5.2 South Korea Antihistamine Drugs Market by Route of Administration
11.3.7.5.3 South Korea Antihistamine Drugs Market by Indication
11.3.7.5.4 South Korea Antihistamine Drugs Market by End User
11.3.7.6 Rest of Asia-Pacific Antihistamine Drugs Market
11.3.7.6.1 Rest of Asia-Pacific Antihistamine Drugs Market by Type
11.3.7.6.2 Rest of Asia-Pacific Antihistamine Drugs Market by Route of Administration
11.3.7.6.3 Rest of Asia-Pacific Antihistamine Drugs Market by Indication
11.3.7.6.4 Rest of Asia-Pacific Antihistamine Drugs Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Antihistamine Drugs Market Overview
11.4.2 Middle East and Africa Antihistamine Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Antihistamine Drugs Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Antihistamine Drugs Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Antihistamine Drugs Market Forecasts and Analysis - By Indication
11.4.6 Middle East and Africa Antihistamine Drugs Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Antihistamine Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Antihistamine Drugs Market
11.4.7.1.1 South Africa Antihistamine Drugs Market by Type
11.4.7.1.2 South Africa Antihistamine Drugs Market by Route of Administration
11.4.7.1.3 South Africa Antihistamine Drugs Market by Indication
11.4.7.1.4 South Africa Antihistamine Drugs Market by End User
11.4.7.2 Saudi Arabia Antihistamine Drugs Market
11.4.7.2.1 Saudi Arabia Antihistamine Drugs Market by Type
11.4.7.2.2 Saudi Arabia Antihistamine Drugs Market by Route of Administration
11.4.7.2.3 Saudi Arabia Antihistamine Drugs Market by Indication
11.4.7.2.4 Saudi Arabia Antihistamine Drugs Market by End User
11.4.7.3 U.A.E Antihistamine Drugs Market
11.4.7.3.1 U.A.E Antihistamine Drugs Market by Type
11.4.7.3.2 U.A.E Antihistamine Drugs Market by Route of Administration
11.4.7.3.3 U.A.E Antihistamine Drugs Market by Indication
11.4.7.3.4 U.A.E Antihistamine Drugs Market by End User
11.4.7.4 Rest of Middle East and Africa Antihistamine Drugs Market
11.4.7.4.1 Rest of Middle East and Africa Antihistamine Drugs Market by Type
11.4.7.4.2 Rest of Middle East and Africa Antihistamine Drugs Market by Route of Administration
11.4.7.4.3 Rest of Middle East and Africa Antihistamine Drugs Market by Indication
11.4.7.4.4 Rest of Middle East and Africa Antihistamine Drugs Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Antihistamine Drugs Market Overview
11.5.2 South and Central America Antihistamine Drugs Market Forecasts and Analysis
11.5.3 South and Central America Antihistamine Drugs Market Forecasts and Analysis - By Type
11.5.4 South and Central America Antihistamine Drugs Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Antihistamine Drugs Market Forecasts and Analysis - By Indication
11.5.6 South and Central America Antihistamine Drugs Market Forecasts and Analysis - By End User
11.5.7 South and Central America Antihistamine Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Antihistamine Drugs Market
11.5.7.1.1 Brazil Antihistamine Drugs Market by Type
11.5.7.1.2 Brazil Antihistamine Drugs Market by Route of Administration
11.5.7.1.3 Brazil Antihistamine Drugs Market by Indication
11.5.7.1.4 Brazil Antihistamine Drugs Market by End User
11.5.7.2 Argentina Antihistamine Drugs Market
11.5.7.2.1 Argentina Antihistamine Drugs Market by Type
11.5.7.2.2 Argentina Antihistamine Drugs Market by Route of Administration
11.5.7.2.3 Argentina Antihistamine Drugs Market by Indication
11.5.7.2.4 Argentina Antihistamine Drugs Market by End User
11.5.7.3 Rest of South and Central America Antihistamine Drugs Market
11.5.7.3.1 Rest of South and Central America Antihistamine Drugs Market by Type
11.5.7.3.2 Rest of South and Central America Antihistamine Drugs Market by Route of Administration
11.5.7.3.3 Rest of South and Central America Antihistamine Drugs Market by Indication
11.5.7.3.4 Rest of South and Central America Antihistamine Drugs Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTIHISTAMINE DRUGS MARKET, KEY COMPANY PROFILES
13.1. BAYER AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALMIRALL S.A.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. JOHNSON AND JOHNSON
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ASTRAZENECA PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVARTIS AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PFIZER, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SANOFI SA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BOEHRINGER INGELHEIM GMBH
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MERCK AND CO.,INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. AKORN, INC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Bayer AG
2. Almirall S.A.
3. Johnson and Johnson
4. AstraZeneca plc
5. Novartis AG
6. Pfizer, Inc.
7. Sanofi SA
8. Boehringer Ingelheim GmbH
9. Merck and Co.,Inc.
10. Akorn, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For